OrderlyMeds’ Response to Eli Lilly’s Cease-and-Desist Letter
On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response. Prescribers and pharmacists have been taking care of...